new_0222_0315|TSHA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
new_0222_0315|TSHA|1|Taysha Gene Therapies Inc Total Current Assets (Quarterly) (USD)|Taysha Gene Therapies Inc Cash and Short Term Investments (Quarterly) (USD)|Taysha Gene Therapies Inc Inventories (Quarterly) (USD)|Taysha Gene Therapies Inc Net PP&E (Quarterly) (USD)|Taysha Gene Therapies Inc Goodwill and Intangibles (Quarterly) (USD)|Taysha Gene Therapies Inc Total Liabilities (Quarterly) (USD)|Taysha Gene Therapies Inc Total Current Liabilities (Quarterly) (USD)|Taysha Gene Therapies Inc Total Long Term Liabilities (Quarterly) (USD)|Taysha Gene Therapies Inc Total Deposits (Quarterly) (USD)|Taysha Gene Therapies Inc Book Value (Quarterly) (USD)|Taysha Gene Therapies Inc Retained Earnings (Quarterly) (USD)|Taysha Gene Therapies Inc Treasury Stock (Quarterly) (USD)|Taysha Gene Therapies Inc EV to Revenues|Taysha Gene Therapies Inc EV to Earnings|Taysha Gene Therapies Inc EV to Free Cash Flow|Taysha Gene Therapies Inc EV to Assets (Quarterly)|Taysha Gene Therapies Inc PS Ratio|Taysha Gene Therapies Inc PE Ratio|Taysha Gene Therapies Inc Price to Book Value|Taysha Gene Therapies Inc PEG Ratio|Taysha Gene Therapies Inc Debt to Equity Ratio|Taysha Gene Therapies Inc Dividend Yield|Taysha Gene Therapies Inc Shareholder Yield (TTM)|Taysha Gene Therapies Inc Percent of Shares Outstanding Short|Taysha Gene Therapies Inc Total Receivables (Quarterly) (USD)|Taysha Gene Therapies Inc Total Payables (Quarterly) (USD)|Taysha Gene Therapies Inc Total Capital Stock (Quarterly) (USD)|Taysha Gene Therapies Inc Return on Invested Capital|Taysha Gene Therapies Inc Quality Ratio Score|Taysha Gene Therapies Inc Momentum Score|Taysha Gene Therapies Inc Beta (1Y)|Taysha Gene Therapies Inc Sustainable Growth Rate (TTM)|Taysha Gene Therapies Inc Institutional Investor Ownership Percentage|Taysha Gene Therapies Inc Average Diluted Shares Outstanding (Quarterly)|Taysha Gene Therapies Inc Total Employees (Annual)|Taysha Gene Therapies Inc EPS Diluted (Quarterly) (USD)|Taysha Gene Therapies Inc SG&A Expense (Quarterly) (USD)|Taysha Gene Therapies Inc Shares Outstanding|Taysha Gene Therapies Inc Repurchase of Capital Stock (Quarterly) (USD)|Taysha Gene Therapies Inc Ordinary Shares Number (Quarterly)|Taysha Gene Therapies Inc Payout Ratio|Taysha Gene Therapies Inc Quick Ratio (Quarterly)|Taysha Gene Therapies Inc Normalized Diluted EPS (Quarterly) (USD)|Taysha Gene Therapies Inc Stock Buybacks (Quarterly) (USD)|Taysha Gene Therapies Inc Effective Tax Rate (TTM)|Taysha Gene Therapies Inc Return on Equity|Taysha Gene Therapies Inc Net Income (TTM) (USD)|Taysha Gene Therapies Inc Revenue (TTM) (USD)|Taysha Gene Therapies Inc Dividend Per Share (Quarterly) (USD)|Taysha Gene Therapies Inc Revenue (Quarterly) (USD)|Taysha Gene Therapies Inc Gross Profit (Quarterly) (USD)|Taysha Gene Therapies Inc Pre-Tax Income (Quarterly) (USD)|Taysha Gene Therapies Inc Net Income (Quarterly) (USD)|Taysha Gene Therapies Inc Net Interest Income (Quarterly) (USD)|Taysha Gene Therapies Inc Price (USD)|Taysha Gene Therapies Inc Total Return Price (USD)|Taysha Gene Therapies Inc Enterprise Value (USD)|Taysha Gene Therapies Inc 30-Day Average Daily Volume|Taysha Gene Therapies Inc 1 Year Price Returns (Daily)|Taysha Gene Therapies Inc Short Interest|Taysha Gene Therapies Inc PE Ratio (Forward)|Taysha Gene Therapies Inc PE Ratio (Forward 1y)|Taysha Gene Therapies Inc PS Ratio (Forward)|Taysha Gene Therapies Inc PS Ratio (Forward 1y)|Taysha Gene Therapies Inc Quarterly EPS Estimates (USD)|Taysha Gene Therapies Inc Quarterly Revenue Estimates (USD)|Taysha Gene Therapies Inc Quarterly EPS Surprise|Taysha Gene Therapies Inc Quarterly Revenue Surprise|Taysha Gene Therapies Inc Quarterly Actual EPS (USD)|Taysha Gene Therapies Inc Quarterly Actual Revenue (USD)|Taysha Gene Therapies Inc Revenue Estimates for Current Fiscal Year (USD)|Taysha Gene Therapies Inc Revenue Estimates for Next Fiscal Year (USD)|Taysha Gene Therapies Inc Price Target (USD)|Taysha Gene Therapies Inc Consensus Recommendation|Taysha Gene Therapies Inc Price Target Num Estimates|Taysha Gene Therapies Inc EPS Estimates for Current Fiscal Year (USD)|Taysha Gene Therapies Inc EPS Estimates for Next Fiscal Year (USD)|Taysha Gene Therapies Inc Research and Development Expense (Quarterly) (USD)|Taysha Gene Therapies Inc Reconciled Depreciation (Quarterly) (USD)|Taysha Gene Therapies Inc Non-Operating Interest Expense (Quarterly) (USD)|Taysha Gene Therapies Inc Land and Improvements (Quarterly) (USD)|Taysha Gene Therapies Inc Buildings and Improvements (Quarterly) (USD)|Taysha Gene Therapies Inc Other Properties (Quarterly) (USD)|Taysha Gene Therapies Inc Machine, Furniture & Equipment (Quarterly) (USD)||
new_0222_0315|TSHA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
new_0222_0315|TSHA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|monthly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0315|TSHA|5|91.4|91.4||91.4||91.4|91.4|91.4||91.4|91.4||||1.44755244755||||1.44571428571|||1.44632768362||15.25||91.4|91.4|||30.6666666667|30.75||30.5|91.2857142857|122|91.2857142857|91.2857142857|28.9333333333||91.4|||91.2857142857|91.25|||91.25|||||91.2857142857|91.2857142857|91.2857142857|1.44632768362|1.44632768362|1.44632768362|1.44923076923|1.44117647059|15.25||||1.44117647059|91.3333333333|91.3333333333|91.25||91.25|91.25|17.3571428571|18.6923076923|13.5|7.47692307692|13.5|14.2941176471|17.3571428571|91.2857142857|91.2857142857|91.2857142857|||91.5|91||
new_0222_0315|TSHA|6|5|5||5||5|5|5||5|5||||286||||350|||354||32||5|5|||3|4||14|7|1|7|7|15||5|||7|4|||4|||||7|7|7|354|354|354|325|102|32||||34|9|9|4||4|4|28|26|36|65|36|34|28|7|7|7|||2|3||
new_0222_0315|TSHA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
new_0222_0315|TSHA|201912||||||||||||||||||||||||||||||||||15.1704||-0.0735|0.128||||||-0.0735|||||||||-1.115|-1.115|||||||||||||||||||||||||0.987||||||||
new_0222_0315|TSHA|202003||||||||||||||||||||||||||||||||||15.1704||-0.358|0.07||||||-0.358|||||||||-5.431|-5.431|-0.027||||||||||||||||||||||||5.514||0.027||||||
new_0222_0315|TSHA|202006|11.299|11.2||0.019||20.09|20.09|||-8.772|-27.766|||||||||||||||1.311||||||||34.5214|10|-0.6147|0.948|||37.7614|||-0.6147|||||||||-21.22|-21.22|||||||||||||||||||||||||3.062||||||||
new_0222_0315|TSHA|202009|279.238|278.634||0.028||11.624|11.624|||267.642|-42.808||||||||3.1604|||||0.676||8.897|||||||99.5598|11.7332||-1.28|3.984|37.7614||37.7614|||-1.28|-167.162|||-42.808|||||-15.042|-15.042|-0.001|22.4|22.4|567.2214|91758.4333||255270|||||0.065||-2069.2308||-1.28||||34.75|1.5|4|-1.4333|-2.3233|11.057|0.003|0.001|||||20.8|22.62
new_0222_0315|TSHA|202012|257.879|251.253||0.287||7.579|7.129|0.45||251.302|-61.126||||-24.4373||||3.988|||||4.7988||1.994||||||||37.7614|38|-0.4851|6.107|37.7614||37.7614|||-0.4851|1.308|||-60.011|||||-18.318|-18.318|0.049|26.54|26.54|750.9346|165804.3667||1812078|||||-0.4933||||||||35|1.5|4|-1.902|-3.115|12.26|0.006|||||0.095|26|25.59
new_0222_0315|TSHA|202103|239.629|228.684||2.497||19.957|18.958|0.999||222.872|-93.15||||-8.8639||||3.4394|||||3.7876||4.083||||||||36.9924||-0.87|8.236|37.7614||37.7614|||-0.87||||-86.604|||||-32.024|-32.024|0.066|20.3|20.3|537.8724|68440.3333||1430258|||||-0.6533||-33.1639||-0.87||||41.3333|1.3333|6|-2.552|-3.122|23.854|0.032||||0.407|0.242|25.81|22.5
new_0222_0315|TSHA|202106|207.302|197.37||33.867||55.365|28.391|26.974||186.495|-134.076||||-7.125||||4.3642|||||4.9369||6.355||||||||37.4792||-1.09|10.129|38.3912||38.3912|||-1.09||||-106.31|||||-40.926|-40.926|-0.154|21.2|21.2|616.5234|255547.3||1895341|||||-0.8591||-26.8784||-1.09||||46.2273|1.2727|11|-3.5787|-3.8889|30.643|0.085|0.194|||0.46|1.205|17.29|19.88
new_0222_0315|TSHA|202109|197.17|188.785||40.553||100.648|43.214|57.434||140.394|-185.263||||-4.7997||||5.1027|||||7.351||22.051||||2|1.4464|||38.004||-1.35|11.153|38.4739||38.4739|||-1.35||||-142.455|||||-51.187|-51.187|-0.506|18.62|18.62|555.411|92407.1333|-16.875|2828228|||||-1.0918||-23.6468||-1.35||||44.8333|1.3333|12|-4.1527|-4.6873|39.528|0.166|0.543|||0.476|1.577|15.64|12.98
new_0222_0315|TSHA|202112|||||||||||||||-2.4823||||3.1926|||||7.8299||||||2|0.5718||91.5081||||||||||||||||||||||11.65|11.65|287.2479|195575.1|-56.104|3012455||||48.5634|-1.2767|||||||7.6913|42.75|1.3077|12|-4.54|-5.1575||||||||7.95|6.48
new_0222_0315|TSHA|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.2989|||||||||||||||||||||
new_0222_0315|TSHA|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.3244|||||||||||||||||||||
new_0222_0315|TSHA|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.3289|||||||||||||||||||||
new_0222_0315|TSHA|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-1.2813|||||||||||||||||||||